Look At Analyst Expectations For A Better Read On Blueprint Medicines Corp (NASDAQ: BPMC)
Currently, there are 64.56M common shares owned by the public and among those 62.27M shares have been available to trade. The company’s stock has a 5-day price change of 0.75% and 61.16% over the past three months. BPMC shares are trading 11.57% year to date (YTD), with the 12-month market performance up to 48.31% higher. […]
Are Analysts Expecting A Better 2020 For Blueprint Medicines Corp (BPMC)?
Blueprint Medicines Corp (BPMC) concluded trading on Thursday at a closing price of $129.33, with 5.98 million shares of worth about $773.9 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 44.44% during that period and on July 10, 2025 the price saw a […]
Blueprint Medicines Corp (NASDAQ: BPMC) – Suitable For Long Term Buy?
Currently, there are 64.56M common shares owned by the public and among those 62.21M shares have been available to trade. The company’s stock has a 5-day price change of 0.14% and 47.62% over the past three months. BPMC shares are trading 46.72% year to date (YTD), with the 12-month market performance up to 20.93% higher. […]
Growing Through Challenges? – Blueprint Medicines Corp (BPMC)
Currently, there are 64.56M common shares owned by the public and among those 62.21M shares have been available to trade. The company’s stock has a 5-day price change of 25.90% and 42.38% over the past three months. BPMC shares are trading 46.51% year to date (YTD), with the 12-month market performance up to 27.07% higher. […]